Pancreatectomy
Pancreatectomy is an intervention with 20 clinical trials. Currently 10 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
10
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
Energy Expenditure and Nutrition After Pancreatic Surgery
WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer
Improvement in Glycemic Response After Bariatric Surgery
Clinical Trials (20)
Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
Energy Expenditure and Nutrition After Pancreatic Surgery
WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer
Improvement in Glycemic Response After Bariatric Surgery
To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease
Endocrine-exocrine Functions and Prognosis After Pancreatectomy
Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma
Delayed Gastric Emptying After Pancreatic Surgery
A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors
Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
The Significance of Postoperative Muscle Wasting in Pancreatic Cancer
Management of Traumatic Pancreas Transection
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Pancreas Volume and Diabetes Status Following Pancreatectomy
Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail
Pancreatic Neuroendocrine Tumor:Factor of Surgery Influencing Survival
Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer
All 20 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 20